# Effect of GLP-1 receptor agonists and co-agonists on atrial fibrillation risk in overweight or obesity: systematic review and meta-analysis of randomized controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-glp-1-receptor-agonists-and-co-agonists-on-atrial-fibrillation-risk-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paschalis Karakasis,Konstantinos Vlachos,Antonios P. Antoniadis,Konstantinos C. Siontis,Dimitrios Patoulias,Nikolaos Fragakis,Christos S. Mantzoros |
| Citations | 22 |
| DOI | 10.1016/j.metabol.2025.156463 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.metabol.2025.156463 |
| OpenAlex ID | https://openalex.org/W4416958402 |
| PMID | 41349790 |
| Type | review |
| Year | 2025 |

## Paper authors

- [Nikolaos Fragakis](https://scholariq.org/researchers/nikolaos-fragakis/)

## Paper journal

- [Metabolism](https://scholariq.org/journals/metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
